Haberkorn, U <br/><br/>
Glucose transport and apoptosis after gene therapy with HSV thymidine kinase.  [electronic resource] 

 -  European journal of nuclear medicine  Nov 2001 
 - 1690-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0340-6997 
<br/><br/><label>Standard No.: </label>10.1007/s002590100644  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3-O-Methylglucose--metabolism<br/>Animals<br/>Antiviral Agents--pharmacology<br/>Apoptosis<br/>Cytochalasin B--pharmacology<br/>Excitatory Amino Acid Transporter 2--metabolism<br/>Fluorodeoxyglucose F18--pharmacokinetics<br/>Ganciclovir--pharmacology<br/>Genetic Therapy<br/>Glucose--metabolism<br/>Glucose Transporter Type 3<br/>Immunohistochemistry<br/>In Situ Nick-End Labeling<br/>Liver Neoplasms, Experimental--metabolism<br/>Male<br/>Monosaccharide Transport Proteins--metabolism<br/>Neoplasm Transplantation<br/>Nerve Tissue Proteins<br/>Radiopharmaceuticals--pharmacokinetics<br/>Rats<br/>Rats, Inbred ACI<br/>Simplexvirus--genetics<br/>Thymidine--metabolism<br/>Thymidine Kinase--genetics<br/>Tumor Cells, Cultured--drug effects